CytoTAb: THA began a Phase IIb placebo-controlled trial

Therapeutic Antibodies Inc. (LSE:THA), London, U.K.
Product: CytoTAb

Read the full 82 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE